Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 12 Sep 2026
British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...
Read Full NewsAI models have not outperformed existing clinical scores for COPD prognosis, but home monitoring may help track disease activity, Bourbeau said.
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
Williams, MD, is joined by Marcus Gates, MD, and they discuss recognizing cervical nerve root and spinal cord compression, navigating treatment options, and determining when surgery may be appropriate.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 6, 2026.
Two-year data from the phase 2 DAZALS trial showed a lower risk of death with dazucorilant 300 mg/day vs placebo in ALS, although the study did not meet its functional primary end point.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the 2026 AHA/ASA Guideline for Adult Stroke Rehabilitation and Recovery!
Newly presented biomarker and clinical findings from the phase 2b PARADIGM trial of PrimeC informed the design of the global phase 3 PARAGON trial in ALS.
1.
Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?
2.
Sports for girls are frequently abandoned due to uniform issues.
3.
New Nanoparticles Can Destroy Undruggable Cancer Proteins
4.
Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities
5.
A specific drug combination is being tested in a clinical trial for the deadly brain cancer glioblastoma.
1.
Emerging Pathways in Hematology for Modern Medicine
2.
Targeting Cancer Stem Cells in Solid Tumors: Mechanisms, Clinical Implications, and Therapeutic Advances
3.
Environmental Carcinogen Exposure Risk Modeling: Current Evidence and Clinical Implications
4.
Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options
5.
Case-Based Learning on Clonal Hematopoiesis With Unexpected Clinical Progression
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
2.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
3.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
5.
Artificial Intelligence for Early Cancer Detection Leveraging Multi-Omics: A Comprehensive Review
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge